Topical Treatment of Herpes Simplex virus Infection with Enzymatically Created siRNA Swarm
Antiviral Therapy2016Vol. 22(7), pp. 631–637
Citations Over TimeTop 15% of 2016 papers
Henrik Paavilainen, Jenni Lehtinen, Alesia Romanovskaya, Michaela Nygårdas, Dennis H. Bamford, Minna M. Poranen, Veijo Hukkanen
Abstract
Treatment with anti-HSV-UL29 siRNA swarm reduced symptoms and viral spread in HSV infection of mice and also inhibited local viral replication in mouse corneas.
Related Papers
- → Recombinant Vaccinia Virus Expressing the Herpes Simplex Virus Type 1 Glycoprotein C Protects Mice against Herpes Simplex Virus Challenge(1989)37 cited
- → Characterization of an H3N2 triple reassortant influenza virus with a mutation at the receptor binding domain (D190A) that occurred upon virus transmission from turkeys to pigs(2010)9 cited
- → Orf virus and vaccinia virus do not cross-protect sheep(1988)17 cited
- → Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells(1985)21 cited
- → The Virulence of West Nile Virus and TP 21 Virus and Their Application to a Group B Arbor Virus Vaccine(1961)15 cited